These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28662514)

  • 61. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
    Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
    Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ferrerol overcomes the invasiveness of lung squamous cell carcinoma cells by regulating the expression of inducers of Epithelial Mesenchymal Transition.
    Li B; Chen P; Wang JH; Li L; Gong JL; Yao H
    Microb Pathog; 2017 Nov; 112():171-175. PubMed ID: 28943152
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
    Da C; Liu Y; Zhan Y; Liu K; Wang R
    Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
    Thacker PC; Karunagaran D
    PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
    Han YT; Chen XH; Gao H; Ye JL; Wang CB
    Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sinapine reverses multi-drug resistance in MCF-7/dox cancer cells by downregulating FGFR4/FRS2α-ERK1/2 pathway-mediated NF-κB activation.
    Guo Y; Ding Y; Zhang T; An H
    Phytomedicine; 2016 Mar; 23(3):267-73. PubMed ID: 26969380
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
    Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
    Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
    Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Rubus idaeus L. reverses epithelial-to-mesenchymal transition and suppresses cell invasion and protease activities by targeting ERK1/2 and FAK pathways in human lung cancer cells.
    Hsieh YS; Chu SC; Hsu LS; Chen KS; Lai MT; Yeh CH; Chen PN
    Food Chem Toxicol; 2013 Dec; 62():908-18. PubMed ID: 24161487
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Ampelopsin reduces the migration and invasion of ovarian cancer cells via inhibition of epithelial-to-mesenchymal transition.
    Liu T; Liu P; Ding F; Yu N; Li S; Wang S; Zhang X; Sun X; Chen Y; Wang F; Zhao Y; Li B
    Oncol Rep; 2015 Feb; 33(2):861-7. PubMed ID: 25502786
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.
    Yang MH; Chen CL; Chau GY; Chiou SH; Su CW; Chou TY; Peng WL; Wu JC
    Hepatology; 2009 Nov; 50(5):1464-74. PubMed ID: 19821482
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting epithelial-to-mesenchymal transition with Met inhibitors reverts chemoresistance in small cell lung cancer.
    Cañadas I; Rojo F; Taus Á; Arpí O; Arumí-Uría M; Pijuan L; Menéndez S; Zazo S; Dómine M; Salido M; Mojal S; García de Herreros A; Rovira A; Albanell J; Arriola E
    Clin Cancer Res; 2014 Feb; 20(4):938-50. PubMed ID: 24284055
    [TBL] [Abstract][Full Text] [Related]  

  • 74. RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin.
    Mi J; Zhang X; Rabbani ZN; Liu Y; Reddy SK; Su Z; Salahuddin FK; Viles K; Giangrande PH; Dewhirst MW; Sullenger BA; Kontos CD; Clary BM
    Mol Ther; 2008 Jan; 16(1):66-73. PubMed ID: 17912235
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of EMT Markers SLUG and TWIST in Breast Cancer.
    Grzegrzolka J; Biala M; Wojtyra P; Kobierzycki C; Olbromski M; Gomulkiewicz A; Piotrowska A; Rys J; Podhorska-Okolow M; Dziegiel P
    Anticancer Res; 2015 Jul; 35(7):3961-8. PubMed ID: 26124343
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biological roles and prognostic values of the epithelial-mesenchymal transition-mediating transcription factors Twist, ZEB1 and Slug in diffuse large B-cell lymphoma.
    Lemma S; Karihtala P; Haapasaari KM; Jantunen E; Soini Y; Bloigu R; Pasanen AK; Turpeenniemi-Hujanen T; Kuittinen O
    Histopathology; 2013 Jan; 62(2):326-33. PubMed ID: 23190132
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of increased accumulation of doxorubicin due to emodin on efflux transporter and LRP1 expression in lung adenocarcinoma and colorectal carcinoma cells.
    Iyer VV; Priya PY; Kangeyavelu J
    Mol Cell Biochem; 2018 Dec; 449(1-2):91-104. PubMed ID: 29644529
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.
    Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB
    Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
    Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
    Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.